TISSUE 2 TARGET
LIVE

Serial Number

97729351

Owner

Cureline, Inc.

Attorney

E. Kate Berezutskaya

First Use Date

Nov 10, 2022

Filing Date

Dec 22, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TISSUE 2 TARGET Trademark

Serial Number: 97729351 • Registration: 7351050

TISSUE 2 TARGET is a trademark filed by Cureline, Inc. on December 22, 2022. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Cureline, Inc. (7 trademarks)

Suite 24
Brisbane, CA 94005

Entity Type: 03

ANALYTICAL BIOLOGICAL SERVICES INC.

2 READS WAY
NEW CASTLE, DE 19720

Entity Type: 03

Trademark Details

Filing Date

December 22, 2022

Registration Date

April 9, 2024

First Use Anywhere

November 10, 2022

First Use in Commerce

November 10, 2022

Published for Opposition

January 23, 2024

Goods & Services

Biomedical research services; development of new technology for others in the fields of genomics and biotechnology; biomedical research services for human specimen banking and laboratory analyses, namely, designing research protocols, drug research and development, research and development in the pharmaceutical and biotechnology fields concerning human tissue and molecular and cellular assays; genotyping services for research or analysis purposes; structural and functional analysis of genomes; laboratory analysis in the fields of genomics and biotechnology; medical and scientific research in the field of cell and molecular profiling and biomarker discovery; gene isolation and gene expression analysis for scientific research purposes; gene mapping for scientific purposes; gene analysis and biomarker discovery for scientific research purposes

Human organ and tissue bank services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; bioinformatics analysis for medical diagnostic and personalized treatment purposes; DNA analysis and screening for medical diagnostic and treatment purposes; consulting services in the field of biological sequence and bioinformatic processing for medical diagnosis and treatment purposes; medical testing, namely, identifying biological drug targets for diagnostic or treatment purposes

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 3, 2026 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 19, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 19, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 19, 2024 REAP
REGISTERED-PRINCIPAL REGISTER
Apr 9, 2024 R.PR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 9, 2024 NRCC
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 15, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 14, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 25, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 25, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 25, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 21, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 20, 2023 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 19, 2023 NWOS
NEW APPLICATION ENTERED
Dec 26, 2022 NWAP